infant formula brand "Yashili" is more exposed to price competition compared with global names such as Friso, Mead Johnson and Wyeth , which benefit from consumers' favorable quality perception. We forecast that intensified competition in the infant formula
NEW YORK, April 28 (Reuters) - A federal judge dismissed claims by former Elan Corp and Wyeth shareholders accusing billionaire investor Steven A. Cohen's SAC Capital Advisors LP of violating federal...
NEW YORK, April 28 (Reuters) - A federal judge has dismissed claims by former Elan Corp and Wyeth shareholders accusing billionaire investor Steven A. Cohen's SAC Capital Advisors LP of violating...
companies control 68% of the market versus just 29% for the top five human-pharmaceutical companies. During the Pfizer/ Wyeth and Merck/Schering mergers, regulators forced significant divestitures of animal-health products while leaving the remaining
it makes sense to own a number of pharmas. Only once have I experienced a dividend cut from a pharma - when Pfizer bought Wyeth they halved their dividend. Other than that, my pharmas just keep sending me money. I watched SNY fall yesterday, today
lot of salespeople. You can cut some R&D. You can streamline manufacturing. It's what Pfizer has done in the past with Wyeth , Pharmacia, and Warner-Lambert. There were secondary drivers, including expanding Pfizer's pipeline. The pipeline as
Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration ..... acceptance triggers a $5 million milestone payment from Wyeth to Progenics and could result in additional milestone and
string of big-ticket mergers. It bought Warner-Lambert in 2000 for $90 billion, Pharmacia in 2003 for $60 billion and Wyeth in 2009 for $68 billion. As a result of those mergers, Pfizer found itself saddled with some businesses it didn’t want
China by 7%-15%, echoing changes made by competitors Danone BN (decreasing prices by 5%-20%), Nestle NESN (its Wyeth unit, acquired from Pfizer PFE , is lowering prices by 6%-20%), Abbott Laboratories ABT (4%-12%), and local competitors
we believe the majority of the efficiency improvements stem from Pfizer's plan to save $4 billion annually following the Wyeth acquisition. We believe Pfizer is likely to achieve this goal. Additionally, Pfizer reaffirmed its full-year 2012 earnings